Medicines as a Service A New Commercial Model for Big Pharma in the Postblockbuster World

The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: Mattke, Soeren (auth)
Eará dahkkit: Klautzer, Lisa (auth), Mengistu, Tewodaj (auth)
Materiálatiipa: Elektrovnnalaš Girjji oassi
Giella:eaŋgalasgiella
Almmustuhtton: RAND Corporation 2012
Fáttát:
Liŋkkat:DOAB: download the publication
DOAB: description of the publication
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Govvádus
Čoahkkáigeassu:The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models.
ISBN:OP381HLTH
9780833076465
Beassan:Open Access